Rion Is A Clinical Stage Regenerative Medicine Company Based In Rochesterminnesotafounded In 2017 Through The Mayo Clinic Employee Entrepreneurial Programthe Company Specializes In Developing Exosome Based Therapeutics Aimed At Addressing Unmet Medical Needs In Areas Such As Non Healing Woundsdegenerative Joint Diseasecardiovascular Illnessand Lung Damage Rion S Flagship Product Is The Purified Exosome Productpepa C Which Is Derived From Platelets And Designed To Promote Tissue Repair And Modulate Inflammatory Responsesthe Technology Is Rooted In The Mayo Clinicae S Van Cleve Cardiac Regenerative Medicine Programand Rion Is Focused On Optimizing Exosome Manufacturing And Therapeutic Applicationsthe Company Engages In Translational Research To Investigate The Efficacy Of Pepa C In Various Clinical Settings And Collaborates With Academic And Clinical Partners To Enhance Its Development Efforts
